4Department of Urology, University of California, 5Teen Cancer America, Los Angeles, CA, USA Abstract: Although there has been significant progress in the survival of children and older adults with cancer in the last few decades, this has not been the case for adolescent and young adults (AYA...
University of California Los Angeles, David Geffen School of Medicine, 4Department of Urology, University of California, 5Teen Cancer America, Los Angeles, CA, USA Abstract&58; Although there has been significant progress in the survival of children and older adults with cancer in the last few ...
Dr. Yutaka Niihara, LA BioMed researcher, developed a promising new treatment for sickle cell disease. Credit: Dana Maione An experimental treatment for sickle cell disease developed at the Los Angeles Biomedical Research Institute (LA BioMed) has entered Phase 3 clinical trials, David I. Meyer, ...
Memorial Sloan-Ketter-ing Cancer Center; New York University; Stanford University; University of California, Los Angeles; University of California, San Diego; University of California, San Francisco; University of Miami; University of Pittsburgh; University of Rochester; University of Southern California...
Clinical trial in post-addicts with oxilorphan (Levo-BC2605): A new narcotic antagonistOxilorphan (levo-BC-2605) is a new, long-acting, narcotic antagonist that has agonist properties. Twenty-one (21) heroin addicts in Los Angeles were detoxified and given at least one oral dose of oxil...
LOS ANGELES--(BUSINESS WIRE)-- Children’s Hospital Los Angeles (CHLA) has launched the first clinical trial for Down syndrome regression disorder (DSRD), a rare and debilitating condition that affects adolescents and young adults with Down...
Trial Name A Phase 1/2, Multi-Center, Open-Label Study to Evaluate the Safety, Tolerability, and Preliminary Anti-tumor Activity of TNG462 as a Single Agent and in Combination in Patients With MTAP-deleted Advanced or Metastatic Solid Tumors ...
When the Cleveland Clinic was looking for participants in its more than 130 cancer trials, its outreach teams didn’t just cold-call doctors and hospitals. They tried something new: they launched an app. TheCancer Trial Appis designed for two distinct populations: patients looking for clinical ...
Today on Medscape : Get the latest medical news, clinical trial coverage, drug updates, journal articles, CME activities & more on Medscape. A free resource for physicians.